Common Contracts
5 similar Employment Agreement contracts by Cellular Biomedicine Group, Inc., SPRINT Corp
EMPLOYMENT AGREEMENT (Amended and Restated as of May 31, 2018)Employment Agreement • July 3rd, 2018 • SPRINT Corp • Telephone communications (no radiotelephone) • Delaware
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of August 11, 2014 (the “Effective Date”) by and between Sprint Corporation, a Delaware corporation (the “Company”) on behalf of itself and any of its subsidiaries, affiliates and related entities and Raul Marcelo Claure (the “Executive”) (the Company and the Executive, collectively, the “Parties,” and each, a “Party”). This Agreement was subsequently amended effective as of November 10, 2014; was amended and restated effective as of August 7, 2015; was amended effective as of January 4, 2018; and is hereby amended and restated effective as of May 31, 2018 (the “Restatement Effective Date”). Certain capitalized terms are defined in Section 30.
EMPLOYMENT AGREEMENTEmployment Agreement • June 28th, 2017 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of June 22, 2017 (the “Effective Date”) by and between Cellular Biomedicine Group Inc., a Delaware corporation (the “Company”) on behalf of itself and any of its subsidiaries, affiliates and related entities and Meng Xia (the “Executive”) (the Company and the Executive, collectively, the “Parties,” and each, a “Party”). Certain capitalized terms are defined in Section 28.
EMPLOYMENT AGREEMENT (Amended and Restated as of March 3, 2017)Employment Agreement • March 13th, 2017 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Maryland
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of August 4, 2015 (the “Effective Date”) by and between Cellular Biomedicine Group Inc., a Delaware corporation (the “Company”) on behalf of itself and any of its subsidiaries, affiliates and related entities and Yihong Yao (the “Executive”) (the Company and the Executive, collectively, the “Parties,” and each, a “Party”). This Agreement is amended and restated effective as of March 3, 2017 (the “Restatement Effective Date”). Certain capitalized terms are defined in
EMPLOYMENT AGREEMENT (Amended and Restated as of March 3, 2017)Employment Agreement • March 13th, 2017 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • California
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of February 6, 2013 (the “Effective Date”) by and between Cellular Biomedicine Group Inc., a Delaware corporation (the “Company”) on behalf of itself and any of its subsidiaries, affiliates and related entities and Andrew Chan (the “Executive”) (the Company and the Executive, collectively, the “Parties,” and each, a “Party”). This Agreement is amended and restated effective as of March 3, 2017 (the “Restatement Effective Date”). Certain capitalized terms are defined in Section 28.
EMPLOYMENT AGREEMENT (Amended and Restated as of March 3, 2017)Employment Agreement • March 13th, 2017 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made and entered into effective as of April 11, 2016 (the “Effective Date”) by and between Cellular Biomedicine Group Inc., a Delaware corporation (the “Company”) on behalf of itself and any of its subsidiaries, affiliates and related entities and Bizuo (Tony) Liu (the “Executive”) (the Company and the Executive, collectively, the “Parties,” and each, a “Party”). This Agreement is amended and restated effective as of March 3, 2017 (the “Restatement Effective Date”). Certain capitalized terms are defined in Section 28.
